Skip to main content
Caplight Logo









IrisMed

IrisMed

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.irismed.co/

Last Round

Seed

Oct 24, 2024

Total Funding Raised

$370,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

IrisMed is a health-tech company that provides an AI-powered platform for optometry practices to automate insurance verification, optical quoting, billing, and patient recall.

Sector

Healthcare & Life Sciences

Verticals

Revenue Cycle, Vertical SaaS, Medical AI, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

revenue cycle managementRCMmedical billing softwaremedical billing automationclaims processinginsurance verificationRCM automationmedical practice managementhealthcare automationAI medical billingrevenue leakagevertical SaaSbilling scrubberspractice management integrationpatient cost transparency

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IrisMed Comparables

Compare IrisMed with similar companies based on industry and business-model similarity.

IrisMed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Toothy AI
87%
SpexBot
83%
RapidClaims
76%

IrisMed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 24, 2024
AcceleratorMar 11, 2024

Key People

Founding team and executive leadership

Shen Lu

Co-founder CPO

Founding Team

IrisMed Investors

Notable investors and investment history

IrisMed investors
InvestorRounds
Baker Bridge CapitalSeed
TechstarsSeed, Accelerator
Atlas SGRSeed
AntlerSeed, Accelerator
Noemis VenturesSeed, Accelerator
Banyan VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 126% MoM, reaching 2.7K.

  • Oct 24, 2024

    $250K raised from Atlas SGR, Techstars, and Antler.

Recent news

Latest coverage and updates

  • integrates_withAug 13, 2026

    IrisMed, Inc. integrates with VSP.

IrisMed Filings

Explore SEC and related filing metadata, where available.

IrisMed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about IrisMed's valuation, stock price, and market status.

Is IrisMed a public or private company?

IrisMed is a private company.

What is the current stock price of IrisMed?

IrisMed is a private company with no public stock price. No recent secondary market data is available.

How much is IrisMed worth (valuation)?

Valuation information for IrisMed is not publicly available.

Can I buy IrisMed stock?

IrisMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was IrisMed's last funding round?

IrisMed's most recent funding round was Accelerator on March 11, 2024.

Who are the main investors in IrisMed?

Key investors in IrisMed include Techstars, Antler AI Disrupt, Noemis Ventures.

Will IrisMed IPO soon?

No public IPO plans have been announced for IrisMed.

How can I track IrisMed secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor IrisMed's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range4
Year Founded2023
Last FundingOct 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?